LEXX CIK: 1348362

Lexaria Bioscience Corp.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
0.18
FY23:
0.19
FY24:
0.46
FY25:
0.70
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.69
FY22:
−6.62
FY23:
−6.53
FY24:
−5.75
FY25:
−11.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.06
FY22:
−5.75
FY23:
−6.17
FY24:
−5.61
FY25:
−11.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.17
FY22:
−7.38
FY23:
−6.71
FY24:
−5.81
FY25:
−11.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.03
FY22:
−7.27
FY23:
−6.66
FY24:
−5.80
FY25:
−11.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data